204 related articles for article (PubMed ID: 8831169)
1. [The efficacy of Turbuhaler dry powder inhaler in Japanese asthma--measurement of peak inspiratory flow when using Turbuhaler].
Kaneko N; Narushima M; Tanaka K; Suzuki H
Arerugi; 1996 Jul; 45(7):649-54. PubMed ID: 8831169
[TBL] [Abstract][Full Text] [Related]
2. Novolizer: how does it fit into inhalation therapy?
Magnussen H
Curr Med Res Opin; 2005; 21 Suppl 4():S39-46; discussion S47. PubMed ID: 16138944
[TBL] [Abstract][Full Text] [Related]
3. Equally efficacious asthma management with budesonide 800 micrograms administered by Turbuhaler or with beclomethasone dipropionate > or = 1500 micrograms given through a pressurized metered-dose inhaler with spacer. The French Budesonide Trial Group.
Piquet J; Zuck P; Dennewald G; Dugue P; Grivaux M; Brun P; Severac JC; Ostinelli J; Cheeseman KH
Adv Ther; 1996; 13(1):38-50. PubMed ID: 10172710
[TBL] [Abstract][Full Text] [Related]
4. [Analysis of inspiratory flow-volume curve].
Narushima M; Tomita S; Tsuzura Y; Kasai T; Endo S; Kaneko N; Yamada M; Ohtsuka H; Akizawa T; Suzuki H
Arerugi; 1998 May; 47(5):493-9. PubMed ID: 9656570
[TBL] [Abstract][Full Text] [Related]
5. Extrafine beclomethasone dipropionate breath-actuated inhaler (400 micrograms/day) versus budesonide dry powder inhaler (800 micrograms/day) in asthma.
Reichel W; Dahl R; Ringdal N; Zetterstrom O; van den Elshout FJ; Laitinen LA
Int J Clin Pract; 2001 Mar; 55(2):100-6. PubMed ID: 11321849
[TBL] [Abstract][Full Text] [Related]
6. Peak inspiratory flow rate and the ability to use the Turbuhaler in Thai children aged 3-7 years.
Tantibhaedhyangkul U; Chatchatee P; Choketeeraswad T; Ngamphaiboon J
J Med Assoc Thai; 2003 Jun; 86 Suppl 2():S201-7. PubMed ID: 12929990
[TBL] [Abstract][Full Text] [Related]
7. A single blinded randomised trial to compare the efficacy and safety of once daily budesonide (400microg) administered by turbuhaler with beclomethasone dipropionate (400microg) given twice daily through a metered-dose inhaler in patients with mild to moderate asthma.
Ige OM; Sogaolu OM
Afr J Med Med Sci; 2004 Jun; 33(2):155-60. PubMed ID: 15565935
[TBL] [Abstract][Full Text] [Related]
8. Emitted dose estimates from Seretide Diskus and Symbicort Turbuhaler following inhalation by severe asthmatics.
Tarsin WY; Pearson SB; Assi KH; Chrystyn H
Int J Pharm; 2006 Jun; 316(1-2):131-7. PubMed ID: 16584855
[TBL] [Abstract][Full Text] [Related]
9. Measurement of peak inspiratory flow with in-check dial device to simulate low-resistance (Diskus) and high-resistance (Turbohaler) dry powder inhalers in children with asthma.
Amirav I; Newhouse MT; Mansour Y
Pediatr Pulmonol; 2005 May; 39(5):447-51. PubMed ID: 15765541
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy of a powder inhaler (Turbuhaler) in moderate asthmatic crises in children].
Rufin P; Benoist MR; Panqueva P; Brouard JJ; De Blic J; Scheinmann P
Rev Mal Respir; 1993; 10(6):545-50. PubMed ID: 8122021
[TBL] [Abstract][Full Text] [Related]
11. Peak inspiratory flow and inspiratory vital capacity of patients with asthma measured with and without a new dry-powder inhaler device (Turbuhaler).
Engel T; Heinig JH; Madsen F; Nikander K
Eur Respir J; 1990 Oct; 3(9):1037-41. PubMed ID: 2289551
[TBL] [Abstract][Full Text] [Related]
12. [Peak inspiratory flow rates attained by asthmatic patients through a dry-powder inhaler of fluticasone propionate].
Fujimori K; Suzuki E; Gejyo F
Arerugi; 2001 Jun; 50(6):551-4. PubMed ID: 11517519
[No Abstract] [Full Text] [Related]
13. Key issues in inhalation therapy in children.
Brand PL
Curr Med Res Opin; 2005; 21 Suppl 4():S27-32. PubMed ID: 16138942
[TBL] [Abstract][Full Text] [Related]
14. Dose response to inhaled terbutaline powder and peak inspiratory flow through Turbuhaler in children with mild to moderate asthma.
Ståhl E; Ribeiro LB; Sandahl G
Pediatr Pulmonol; 1996 Aug; 22(2):106-10. PubMed ID: 8875584
[TBL] [Abstract][Full Text] [Related]
15. The impact of inspiratory effort on inspiratory flow through Turbuhaler in asthmatic patients.
Persson G; Olsson B; Soliman S
Eur Respir J; 1997 Mar; 10(3):681-4. PubMed ID: 9073005
[TBL] [Abstract][Full Text] [Related]
16. [Peak inspiratory flow using 2 different inhalers and a new portable device].
García-Marcos Alvarez L; Martínez Torres A; Guillén Pérez JJ; Martínez Victoria A
An Esp Pediatr; 2001 Feb; 54(2):110-3. PubMed ID: 11181205
[TBL] [Abstract][Full Text] [Related]
17. Patient perception of the diskus inhaler: a comparison with the turbuhaler inhaler.
Schlaeppi M; Edwards K; Fuller RW; Sharma R
Br J Clin Pract; 1996; 50(1):14-9. PubMed ID: 8729596
[TBL] [Abstract][Full Text] [Related]
18. [An evaluation of the acceptance of budesonide turbuhaler by older Japanese patients with bronchial asthma when changed from fluticasone propionate (FP) or beclomethasone dipropionate (BDP)].
Ohbayashi H; Yamase H
Arerugi; 2003 Jan; 52(1):31-8. PubMed ID: 12598720
[TBL] [Abstract][Full Text] [Related]
19. [Easyhaler--ideal dry powder inhaler].
Andrzej E; Małgorzata BE
Pol Merkur Lekarski; 2010 Apr; 28(166):307-10. PubMed ID: 20491343
[TBL] [Abstract][Full Text] [Related]
20. [Measurement of peak inspiratory flow with asthma: effect of inhaled beta2-stimulant].
Shimizu K; Yamazaki Y; Kishimoto N; Tada S; Ueda N; Fujita J; Kamei T; Okada H; Arakawa Y; Nakamura H
Nihon Kokyuki Gakkai Zasshi; 2005 Apr; 43(4):216-20. PubMed ID: 15966367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
